Glycated haemoglobin (haemoglobin A1c or HbA1c) level has long been utilised for assessment of long-term glycaemic control in patients with diabetes mellitus.1 More recently it has also been included as a criterion for the diagnosis of type 2 diabetes mellitus.2 However, use of HbA1c as a diagnostic tool for diabetes is controversial.3 This article discusses some of the limitations, and explores whether HbA1c should be recommended for diagnosis of diabetes mellitus in Malawi and similar settings.
No takes yet. Share an insight, caveat, or question.
Nakanga et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: